Skip to Main Content

Holland & Hart Represents BayMedica in Acquisition by InMed Pharmaceuticals

Holland & Hart represented BayMedica Inc., a private company specializing in the manufacturing and commercialization of rare cannabinoids for the health and wellness sector, in its acquisition by InMed Pharmaceuticals Inc., a leader in the manufacturing and clinical development of rare cannabinoids.

The transaction combines the organizations’ capabilities and resources to accelerate BayMedica’s commercial initiatives and expedite the launch of several new cannabinoids products in the consumer health and wellness sector. The combined technologies in rare cannabinoid manufacturing, in three distinct and complementary manufacturing approaches, establishes the company as a leader in the field.

The Holland & Hart transactional team was led by corporate partner David Garcia, with assistance from Todd Criger, Robert Denzer, Peter Perla, Trent Timmons, John Wilson, John Ludlum, Mark Wiletsky, and Lori Argall.

For more information, please view InMed’s press release.

Holland & Hart’s Corporate attorneys have extensive experience advising clients from start-ups to public companies, at all stages of development, in a diverse range of industries, including healthcare, construction and building materials, energy and resources, technology, finance, gaming, outdoor recreation, animal health, aerospace, and food, beverage, and consumer products industries.


Unless you are a current client of Holland & Hart LLP, please do not send any confidential information by email. If you are not a current client and send an email to an individual at Holland & Hart LLP, you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us, unless we have already agreed to represent you or we later agree to do so. Thus, we may represent a party adverse to you, even if the information you submit to us could be used against you in a matter, and even if you submitted it in a good faith effort to retain us.